{"id":"https://openalex.org/W4390126224","doi":"https://doi.org/10.1016/j.jval.2023.09.223","title":"CO151 Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists With the Risk of Developing Dementia in People With Type 2 Diabetes Mellitus","display_name":"CO151 Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists With the Risk of Developing Dementia in People With Type 2 Diabetes Mellitus","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4390126224","doi":"https://doi.org/10.1016/j.jval.2023.09.223"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2023.09.223","doi":"https://doi.org/10.1016/j.jval.2023.09.223","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.223","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)03353-3/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)03353-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"J. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Wang","raw_affiliation_strings":["University of Birmingham, Birmingham, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, LON, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046211745","display_name":"Konstantinos A. Toulis","orcid":"https://orcid.org/0000-0002-2044-4253","observed_orcids":["https://orcid.org/0000-0002-2044-4253"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. Toulis","raw_affiliation_strings":["University of Birmingham, Birmingham, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, LON, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004886844","display_name":"Krishna Margadhamane Gokhale","orcid":"https://orcid.org/0000-0002-2167-9572","observed_orcids":["https://orcid.org/0000-0002-2167-9572"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. Gokhale","raw_affiliation_strings":["University of Birmingham, Birmingham, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, LON, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069048116","display_name":"Nicola Jaime Adderley","orcid":"https://orcid.org/0000-0003-0543-3254","observed_orcids":["https://orcid.org/0000-0003-0543-3254"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N.J. Adderley","raw_affiliation_strings":["University of Birmingham, Birmingham, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, LON, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Clark","raw_affiliation_strings":["Cegedim, North Harrow, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cegedim, North Harrow, LON, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Dhalla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Dhalla","raw_affiliation_strings":["Cegedim, North Harrow, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cegedim, North Harrow, LON, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Seck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098847","display_name":"Cegedim (France)","ror":"https://ror.org/012bs5594","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210098847"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Seck","raw_affiliation_strings":["Cegedim Health Data, Boulogne Billancourt, 92, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cegedim Health Data, Boulogne Billancourt, 92, France","institution_ids":["https://openalex.org/I4210098847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016610763","display_name":"Krishnarajah Nirantharakumar","orcid":"https://orcid.org/0000-0002-6816-1279","observed_orcids":["https://orcid.org/0000-0002-6816-1279"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. Nirantharakumar","raw_affiliation_strings":["University of Birmingham, Birmingham, LON, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, LON, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069020661","display_name":"C. Eteve-Pitsaer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098847","display_name":"Cegedim (France)","ror":"https://ror.org/012bs5594","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210098847"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Eteve-Pitsaer","raw_affiliation_strings":["Cegedim Health Data, Boulogne-Billancourt, 92, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cegedim Health Data, Boulogne-Billancourt, 92, France","institution_ids":["https://openalex.org/I4210098847"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"12","first_page":"S41","last_page":"S42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dementia-risk","display_name":"dementia risk","score":0.8619999885559082},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.6370000243186951},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6991859674453735},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6598442792892456},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6070231795310974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5990115404129028},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5279970169067383},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5182573795318604},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5081710815429688},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.49791932106018066},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4684799909591675},{"id":"https://openalex.org/C188053792","wikidata":"https://www.wikidata.org/wiki/Q3640664","display_name":"Cotransporter","level":3,"score":0.4183782637119293},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.40304315090179443},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.3947333097457886},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2935889959335327},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1253478229045868},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.06635385751724243},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2023.09.223","doi":"https://doi.org/10.1016/j.jval.2023.09.223","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.223","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)03353-3/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2023.09.223","doi":"https://doi.org/10.1016/j.jval.2023.09.223","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.223","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)03353-3/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390126224.pdf","grobid_xml":"https://content.openalex.org/works/W4390126224.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412620797","https://openalex.org/W4401873288","https://openalex.org/W4416766247","https://openalex.org/W4394600275","https://openalex.org/W4416323240","https://openalex.org/W4407393044","https://openalex.org/W4391716946","https://openalex.org/W4311187428","https://openalex.org/W7214768539","https://openalex.org/W4409377239"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-23T00:00:00"}